
Opinion|Videos|August 30, 2024
Biomarkers as Tools in Management of Type 2 Inflammation
Author(s)Reynold A. Panettieri Jr, MD
An expert in COPD delves into biomarkers indicative of type 2 inflammation and recommends diagnostic tests for assessing inflammation in COPD patients.
Advertisement
Episodes in this series

- What biomarkers can reliably assess the presence of type 2 inflammation as a contributing factor in asthma or COPD?
- How can absolute eosinophil count specifically be used as a tool in this population for regimen selection? Does this biomarker have a role in predicting treatment response or patient outcomes?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
2
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
3
ESMO Congress Marks 50 Years by Showcasing the Future of Cancer Care: Vivek Subbiah, MD
4
Medical School Diversity Declines Following Affirmative Action Repeal
5